Abbott Laboratories
XBER:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XBER:ABL
|
US |
|
UBE Corp
TSE:4208
|
JP |
|
G
|
General Mills Inc
XMUN:GRM
|
US |
|
V
|
Vinci SA
F:SQUA
|
FR |
|
CETC Acoustic-Optic-Electronic Technology Inc
SSE:600877
|
CN |
|
G
|
Gatos Silver Inc
TSX:GATO
|
US |
|
ContextVision AB
OSE:CONTX
|
SE |
|
Artisan Partners Asset Management Inc
NYSE:APAM
|
US |
|
F
|
First National Corp
NASDAQ:FXNC
|
US |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
|
Italian Exhibition Group SpA
MIL:IEG
|
IT |
|
ON Semiconductor Corp
NASDAQ:ON
|
US |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 147.1 EUR with a low forecast of 111.99 EUR and a high forecast of 180.97 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
147.1
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 147.1 EUR with a low forecast of 111.99 EUR and a high forecast of 180.97 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
